3rd Medical Affairs & Rare Disease

East Coast

November 9-10, 2020

Boston, MA

Event Overview

Dynamic Global Events is excited to announce the 3rd Annual Medical Affairs in Rare Diseases Forum.

Join us for the 3rd Annual Medical Affairs in Rare Diseases Forum to become a strong and collaborative partner who will drive medical strategy of the Launch and Brand Plan of orphan drugs. Learn to better ensure the execution of medical affairs programs, provide medical expertise, training and support to the cross-functional teams and work closely with the patient community.

The Inn at Penn, a Hilton Hotel

Image

3600 Sansom St,
Philadelphia, PA 19104
(215) 222-0200

Hotel Website

Special Event Rate
Book Today!

About the Chairperson

Image

Dr. Matthew T. Roe has been a faculty member at Duke University School of Medine and the Duke Clinical Research Institute (DCRI) since 1999. As a senior investigator at the DCRI, he has been the principal investigator for numerous phase II-IV cardiovascular clinical trials and is currently a co-principal investigator for the ADAPTABLE trial—the first large-scale pragmatic trials being conducted in the PCORnet network. He has also served in leadership roles for several observational registries focusing upon the treatment and outcomes of patients with cardiovascular disease and has served as the Director of the DCRI Clinical Research Fellowship since 2010.

Featured Speakers

Image

Craig Lipset

Head of Clinical Innovation
Pfizer

Image

Jeff Kingsley

Chief Executive Officer
IACT Health 

Image

Dawn Anderson

Managing Director, Life Sciences Strategy and Operations, R&D Practice
Deloitte

Image

Ross Friedberg

General Counsel & Chief Privacy Officer
Doctor on Demand

Top Reasons to Attend

  1. Discover how medical affairs teams are creating advanced strategies and achieving success in rare disease markets
  2. Optimize your medical affairs’ ability to understand patient needs and create patient-centric medical information
  3. Understand the regulatory pathway and nuances for the orphan drug approval process and the value of natural history studies
  4. Ensure that key insights/analyses, opportunities and challenges, strategic priorities are developed as part of a cross-functional team approach to maximize alignment

Attendee Profile

This Conference is Designed for Life Science Professionals responsible for:

  • Medical Affairs
  • Medical Engagement
  • Product Development
  • Medical Science Liaison
  • Medical Information
  • Medical Communication
  • Scientific Communications
  • Rare Disease
  • Patient Engagement
  • Field Medical Teams

Monday

November 9th, 2020 | Day 1

8:00 AM - 9:00 AM

Registration & Continental Breakfast

9:00 AM - 9:15 AM

Conference Opening Remarks

9:15 AM - 10:00 AM

Medical Affairs as the Strategic Driver within an Organization

Isabel Firmino - Vice President, Head of Global Medical Affairs Therapeutic Areas
ALEXION PHARMACEUTICALS, INC.

10:00 AM - 10:45 AM

Creating Strategic Plans for Cross Functional Collaboration and Growth

Andy Overmyer - Head of Global Business Operations
AKCEA THERAPEUTICS

10:45 AM - 11:00 AM

Morning Networking Break

11:00 AM - 12:00 PM

Collaborative Private/Public Partnerships for Real World Evidence Collection and Expanded Access to Rare Disease Therapies

Wendy White - Chairman
GLOBAL GENES
Co-Founder, RAREITI

Natalie Douglas - Vice Chairman
GLOBAL GENES
Co-Founder, RAREITI

12:00 PM - 1:00 PM

Networking Lunch

1:00 PM - 1:45 PM

Collaborating Around Rare Disease

Jon Kaskey - Regional Vice President, Business Partnerships
WITHIN3

1:45 PM - 2:45 PM

PANEL: Rare Disease Clinical Research: Literacy, Diversity, Engagement, Technology and Retention

Joan A. Chambers - Senior Director, Marketing and Outreach
CENTER FOR INFORMATION & STUDY ON CLINICAL RESEARCH PARTICIPATION (CISCRP)

Harsha Rajasimha, MS, Ph.D - Founder and CEO
JEEVA INFORMATICS SOLUTIONS INC.

2:45 PM - 3:00 PM

Afternoon Networking Break

3:00 PM - 4:00 PM

Medical Communications

Ana Bozas - Associate Director, Medical Communications
AKCEA THERAPEUTICS

4:00 PM - 4:45 PM

PANEL: The Impact of Technology on Patient Engagement

  • Recruiting
  • Hybrid and Virtual Clinical Trials
  • Digital Marketing and Convenience-based Applications

Joan A. Chambers - Senior Director, Marketing and Outreach
CENTER FOR INFORMATION & STUDY ON CLINICAL RESEARCH PARTICIPATION (CISCRP)

Harsha Rajasimha, MS, Ph.D - Founder and CEO
JEEVA INFORMATICS SOLUTIONS INC.

4:45 PM - 5:00 PM

Day 1 Closing Remarks

Tuesday

November 10th, 2020 | Day 2

8:00 AM - 9:00 AM

Registration & Continental Breakfast

9:00 AM - 9:15 AM

Recap of Day 1 & Day 2 Opening Remarks

9:15 AM - 10:00 AM

HEOR and Determining the Value of Rare Disease Therapies Digital Tools for the Benefit-Risk Optimization of Therapies in Rare

10:00 AM - 10:45 AM

Knowledge Transfer Challenges in Rare Disease

Shweta Rane, Ph.D., CMPP - Director Global Scientific Communications
ALEXION PHARMACEUTICALS, INC.

10:45 AM - 11:00 AM

Morning Networking Break

11:00 AM - 12:00 PM

PANEL: Expanding and Changing Role of MSLs in Rare Disease

Moderator:

Sheila Bose, President
SB LIFESCIENCES CONSULTING, INC.

12:00 PM - 1:00 PM

Networking Lunch

1:00 PM - 1:45 PM

Sponsor Session Topic TBD

Robert Consalvo - Director of Strategic Commercial Engagement
H1 INSIGHTS

1:45 PM - 2:30 PM

Thinking About Experience Differently – Clinical Trial Partnerships with Medical Affairs

Derek Ansel - Director of Rare and Orphan Diseases
SYNTERACT

2:30 PM - 2:45 PM

Afternoon Networking Break

2:45 PM - 4:45 PM

MEDICAL AFFAIRS RARE DISEASE CASE STUDY PRACTICUM
BEST PRACTICES FOR BREAKING DOWN SILOS TO IDENTIFY SOLUTIONS

  • Actionable Implications to Achieve Clinical Development, Product Launch Goals, Drug Safety and Favorable Outcomes
  • Building High-performing Multi-stakeholder Teams
  • Leading Internal Project Teams Across Functions, Geographies and Therapeutic Areas
  • Collaborating Across Organizations -- Science, Business and Non-profits

4:45 PM - 5:00 PM

Day 2 Closing Remarks

FEATURED SPEAKERS

Image

Ana Bozas

Akcea Therapeutics

Associate Director, Medical Communications

Image

Isabel Firmino

Alexion Pharmaceuticals, Inc.

Vice President, Head of Global Medical Affairs Therapeutic Areas

Image

Shweta Rane

Alexion Pharmaceuticals, Inc.

Director of Global Scientific Communications

Image

Joan A. Chambers

The Center for Information & Study on Clinical Research Participation

Senior Director, Marketing & Outreach

Image

Sheila Bose

SB Lifesciences Consulting, Inc.

President

Image

Derek Ansel

Synteract

Director of Rare and Orphan Diseases

Andy Overmyer

Andy Overmyer

Akcea Therapeutics

Head of Global Business Operations

Wendy White

Wendy White

GLOBAL GENES

Chairman

Co-Founder, RAREITI

Natalie Douglas

Natalie Douglas

GLOBAL GENES

Vice Chairman

Co-Founder, RAREITI

Natalie Douglas

Harsha K. Rajasimha

Jeeva Informatics Solutions Inc.

Founder and CEO

Founder Chairman, Indo US Organization for Rare Diseases

Natalie Douglas

Israel Gutierrez

Geron Corporation

Vice President, Pharmacovigilance and Drug Safety

CONFERENCE REGISTRATION


IN-PERSON ATTENDEE

* SUPER EARLY BIRD *

Before 8/21/20

$1,596

EARLY BIRD

Before 9/25/20

$1,796

STANDARD

After 9/25/20

$1,996

ON-SITE

Register at Event

$2,196

LIVE STREAM ATTENDEE

EARLY BIRD

Before 9/25/20

$796

STANDARD

After 9/25/20

$896

Register 2 Attendees, Get 1 Complimentary Registration*!

Interested in sending groups of 7 or more? Contact us directly for pricing.

EVENT SPONSORS


Scarritt Group - Official Media Partner

OFFICIAL LIVESTREAM PROVIDER


SPONSOR THIS EVENT

Contact Amy Chapman at (561) 571-7687 or achapman@dgeconfs.com

MEDIA PARTNERS


PM360 - Media Partner

PREMIER MEDIA PARTNER